Patent · US Active

Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones

US9649314B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Edgar Jacoby · Beerse, BE
Juergen REINHARDT · Hilden, DE
Niko Schmiedeberg · Riehen, CH
Carsten Spanka · Bad Kötzting, DE

Key dates

Filing date	Dec 12, 2013
Grant date	May 16, 2017
Priority date	—
Expiry date	Dec 12, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compound of the formula (I); or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.